Avance Clinical is the largest specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand and North America for international biotechs.
The CRO has been delivering clinical drug development services for international biotechs for FDA and EMA regulatory approval, for more than two decades.
Early to Late Phase
Avance Clinical Australia and New Zealand teams focus on servicing biotech clients in their early phases of drug development delivering fast, nimble, and adaptive client-oriented solutions. In collaboration with our US operations, we also deliver later-phase CRO services.
Fast, nimble, and adaptive solutions
Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.